Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Amplio Pharma AB
AB
Active
Org 5592371073
Lund
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2020 · 6 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Amplio Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
SEK millions
1M
1M
1M
0M
0M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 1M
1M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
89
255
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
1 218
−28
−285
−134
−6
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
1 218
−28
−285
−134
−6
Net financials
−92
−76
−72
−49
—
Profit before tax
1 126
−104
−357
−182
−6
Tax
−101
−0
−0
−0
−0
Net profit
1 025
−104
−357
−182
−6
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
2 850
1 573
1 630
1 465
19
Equity
1 129
45
149
187
19
Long-term debt
1 553
1 521
1 445
1 224
0
Short-term debt
167
7
36
55
0
Total debt
1 720
1 528
1 481
1 279
—
Financial ratios
5-year trend
EBITDA margin
>999%
This company
15.8%
Market median
This company
Market median
>999% above market
2021
2025
Equity ratio
39.6%
This company
38.2%
Market median
This company
Market median
4% above market
2021
2025
Return on equity
90.8%
This company
18.4%
Market median
This company
Market median
393% above market
2021
2025
Net profit margin
>999%
This company
8.1%
Market median
This company
Market median
>999% above market
2021
2025
Asset turnover
0.03×
This company
1.12×
Market median
This company
Market median
97% below market
2021
2025
Debt / equity
1.52×
This company
0.62×
Market median
This company
Market median
145% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2021-04-30
View
PDF
More on Amplio Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
